Dividend Roundup: Why I Prefer Johnson & Johnson Over Pfizer
Johnson & Johnson offers safer payouts and stronger growth. Discover why JNJ stock is the better dividend option compared to ...
Pfizer price target lowered to $29 from $31 at UBS
UBS lowered the firm’s price target on Pfizer (PFE) to $29 from $31 and keeps a Neutral rating on the shares as part of a broader note on the ...
Truist Financial Sticks to Its Buy Rating for Pfizer (PFE)
In a report released yesterday, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Pfizer (PFE – Research Report), with a ...
Moderna, Novavax and other vaccine names extend gains amid COVID/flu concerns
Novavax (NASDAQ:NVAX), and other vaccine developers extended recent gains on Tuesday as investors reacted to rising flu and ...
Hosted on MSN1d
Is Trending Stock Pfizer Inc. (PFE) a Buy Now?
Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...